Adrian M Jones - Net Worth and Insider Trading
Adrian M Jones Net Worth
The estimated net worth of Adrian M Jones is at least $792 Million dollars as of 2024-04-19. Adrian M Jones is the Director of Sterling Check Corp and owns about 49,808,542 shares of Sterling Check Corp (STER) stock worth over $740 Million. Adrian M Jones is the Director of Dollar General Corp and owns about 360,055 shares of Dollar General Corp (DG) stock worth over $53 Million. Adrian M Jones is also the Director of T2 Biosystems Inc and owns about 84,032 shares of T2 Biosystems Inc (TTOO) stock worth over $251,256. Details can be seen in Adrian M Jones's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Adrian M Jones has not made any transactions after 2023-12-22 and currently still holds the listed stock(s).
Transaction Summary of Adrian M Jones
Adrian M Jones Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Adrian M Jones owns 5 companies in total, including T2 Biosystems Inc (TTOO) , Dollar General Corp (DG) , and Education Management Corp (EDMCQ) among others .
Click here to see the complete history of Adrian M Jones’s form 4 insider trades.
Insider Ownership Summary of Adrian M Jones
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TTOO | T2 Biosystems Inc | 2020-05-20 | director |
DG | Dollar General Corp | 2013-12-11 | director |
EDMCQ | Education Management Corp | 2013-11-08 | director |
UCI | UBS AG Jersey ZC SP ETRACS REDEEM 05/04/2038 USD 25 - 902641778 | 2006-04-05 | director |
STER | Sterling Check Corp | 2023-12-22 | director |
Adrian M Jones Latest Holdings Summary
Adrian M Jones currently owns a total of 3 stocks. Among these stocks, Adrian M Jones owns 49,808,542 shares of Sterling Check Corp (STER) as of December 22, 2023, with a value of $740 Million and a weighting of 93.34%. Adrian M Jones owns 360,055 shares of Dollar General Corp (DG) as of December 11, 2013, with a value of $53 Million and a weighting of 6.63%. Adrian M Jones also owns 84,032 shares of T2 Biosystems Inc (TTOO) as of May 20, 2020, with a value of $251,256 and a weighting of 0.03%.
Latest Holdings of Adrian M Jones
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
STER | Sterling Check Corp | 2023-12-22 | 49,808,542 | 14.85 | 739,656,849 |
DG | Dollar General Corp | 2013-12-11 | 360,055 | 145.96 | 52,553,628 |
TTOO | T2 Biosystems Inc | 2020-05-20 | 84,032 | 2.99 | 251,256 |
Holding Weightings of Adrian M Jones
Adrian M Jones Form 4 Trading Tracker
According to the SEC Form 4 filings, Adrian M Jones has made a total of 5 transactions in Sterling Check Corp (STER) over the past 5 years, including 1 buys and 4 sells. The most-recent trade in Sterling Check Corp is the acquisition of 157 shares on December 22, 2023, which cost Adrian M Jones around $2,110.
According to the SEC Form 4 filings, Adrian M Jones has made a total of 0 transactions in Dollar General Corp (DG) over the past 5 years. The most-recent trade in Dollar General Corp is the sale of 899,475 shares on December 11, 2013, which brought Adrian M Jones around $55 Million.
According to the SEC Form 4 filings, Adrian M Jones has made a total of 2 transactions in T2 Biosystems Inc (TTOO) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in T2 Biosystems Inc is the acquisition of 925 shares on May 20, 2020, which cost Adrian M Jones around $29,603.
Insider Trading History of Adrian M Jones
- 1
Adrian M Jones Trading Performance
GuruFocus tracks the stock performance after each of Adrian M Jones's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Adrian M Jones is 52.01%. GuruFocus also compares Adrian M Jones's trading performance to market benchmark return within the same time period. The performance of stocks bought by Adrian M Jones within 3 months outperforms 3 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Adrian M Jones's insider trading performs compared to the benchmark.
Performance of Adrian M Jones
Average Return
40.33%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 29.04 | 52.01 | 41.74 | 40.33 | -11.11 | -2.6 |
Relative Return to S&P 500(%) | 26.76 | 43.34 | 26.26 | 10.27 | -25.2 | -13.25 |
Adrian M Jones Ownership Network
Ownership Network List of Adrian M Jones
Ownership Network Relation of Adrian M Jones
Adrian M Jones Owned Company Details
What does T2 Biosystems Inc do?
Who are the key executives at T2 Biosystems Inc?
Adrian M Jones is the director of T2 Biosystems Inc. Other key executives at T2 Biosystems Inc include 10 percent owner Cr Group L.p. , 10 percent owner Crg Partners Iii (cayman) Unlev Aiv I L.p. , and 10 percent owner Crg Partners Iii (cayman) Lev Aiv I L.p. .
T2 Biosystems Inc (TTOO) Insider Trades Summary
Over the past 18 months, Adrian M Jones made no insider transaction in T2 Biosystems Inc (TTOO). Other recent insider transactions involving T2 Biosystems Inc (TTOO) include a net sale of 48,345,798 shares made by Cr Group L.p. , a net sale of 2,366 shares made by Brett A. Giffin , and a net sale of 3,969 shares made by Michael Terrence Gibbs .
In summary, during the past 3 months, insiders sold 0 shares of T2 Biosystems Inc (TTOO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 48,364,599 shares of T2 Biosystems Inc (TTOO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 48,364,599 shares.
T2 Biosystems Inc (TTOO)'s detailed insider trading history can be found in Insider Trading Tracker table.
T2 Biosystems Inc Insider Transactions
Adrian M Jones Mailing Address
Above is the net worth, insider trading, and ownership report for Adrian M Jones. You might contact Adrian M Jones via mailing address: C/o Goldman, Sachs & Co., 85 Broad Street, New York Ny 10004.